Trump determined to link life-saving shots to autism, despite science and political risk.
  • Delta_V@lemmy.worldEnglish
    631·
    1 month ago

    Remember when Tylenol was linked to autism, crashing the stock price of its maker just long enough for that business to be acquired at a steep discount by its new owner? And how we never heard about a link between Tylenol and autism again?

    I wonder which vaccine maker is about to get a hostile takeover?

      • Random Dent@lemmy.mlEnglish
        17·
        1 month ago

        Kimberly-Clark apparently.

        In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson’s Baby, Sudafed, Visine, and Zyrtec brands to the company’s portfolio.

        But also…

        Kimberly-Clark shares are mainly held by institutional investors (The Vanguard Group, BlackRock, State Street Corporation, and others).

        So make of that what you will.

        • green_goglin@thelemmy.club
          4·
          1 month ago

          Vanguard runs VOO and StateStreet runs SPY which are S&P500 ETF / Index Funds. That is why they have equity ownership in Kimberly-Clark.

        • obviouspornalt@fedinsfw.appEnglish
          3·
          1 month ago

          In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson’s Baby, Sudafed, Visine, and Zyrtec brands to the company’s portfolio.[34][35]